Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report

Hum Psychopharmacol. 2003 Aug;18(6):477-8. doi: 10.1002/hup.506.

Abstract

This communication describes a patient who developed Schneiderian first-rank symptoms in the course of treatment with fluvoxamine. The patient, a 28-year-old man suffering from panic disorder, developed several first-rank symptoms during fluvoxamine administration. These symptoms abated 1 week after fluvoxamine treatment was discontinued and haloperidol was started. Although haloperidol was discontinued, no further hallucinations or delusions occurred. This finding suggests that fluvoxamine can precipitate Schneiderian first-rank symptoms in some susceptible patients.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Delusions / chemically induced*
  • Delusions / diagnosis
  • Delusions / drug therapy
  • Diagnosis, Differential
  • Fluvoxamine / adverse effects*
  • Fluvoxamine / therapeutic use
  • Hallucinations / chemically induced*
  • Hallucinations / diagnosis
  • Hallucinations / drug therapy
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Panic Disorder / drug therapy*
  • Panic Disorder / psychology
  • Treatment Outcome

Substances

  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Haloperidol
  • Fluvoxamine